Prostate cancer drugs may cloud your mind: new study investigates
NCT ID NCT03016741
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how certain hormone therapies for advanced prostate cancer might affect memory, thinking, and brain structure. Researchers will use brain scans and thinking tests in 100 men to track changes over time. The goal is to understand which patients are more likely to experience mental side effects and why.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CASTRATION RESISTANT PROSTATIC CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
City of Hope Comprehensive Cancer Center
Los Angeles, California, 91010, United States
-
Northwestern University
Chicago, Illinois, 60611, United States
-
Tulane Cancer Center
New Orleans, Louisiana, 70112, United States
-
University of Minnesota: Masonic Cancer Center
Minneapolis, Minnesota, 55455, United States
-
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, 37232, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New PET tracer could reveal hidden prostate cancer
- Experimental pill SHY-ONC6 takes on Hard-to-Treat cancers
- New hope for advanced bladder cancer? bevacizumab combo tested
- Intermittent fasting tested to ease radiation side effects in cancer patients
- Supercharged immune cells take on Hard-to-Treat prostate cancer
- New scan could sharpen radiation targeting for recurrent prostate cancer